Abstract: A toothbrush having a resiliently flexible composite region between its head and handle which comprises one or members of generally triangular shape in section either made of a resilient elastomeric material different to the hard plastic material of the toothbrush head and handle, or made of a hard plastic material.
February 27, 2002
Date of Patent:
December 30, 2003
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
Abstract: This invention is an improved method for reducing or eliminating tobacco usage and the nicotine dependency associated with tobacco usage by gradually decreasing an individual's tobacco consumption over a time period while replacing nicotine from tobacco with an alternative nicotine source.
Abstract: A method of treating a CNS injury to the brain, in a mammal in need of treatment, which comprises administering to said mammal an effective amount of a cytokine suppressive binding protein compound of formula I
wherein the radicals are defined herein.
Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable rapidly disintegrating methylcellulose and lipstatin derivatives together in combination with a suitable diluent and excipients.
Abstract: A process for preparing an aqueous composition for the preparation of optically clear products, especially beverages, having enhanced stability in syrup and bioavailability for human or animal healthcare. The compositions include an oil soluble ingredient and a primary and a secondary surfactant which match the fatty acid profile of the oil soluble ingredient and follow specific ratios of oil soluble ingredient to emulsifier and specific ratios of primary to cosurfactant.
April 2, 2001
Date of Patent:
January 21, 2003
SmithKline Beecham p.l.c.
Maarten Van Den Braak, Andrew Symonds, Michael Anthony Ford
Abstract: A method for separating a blood component, e.g., fibrin monomer, from blood or plasma. The method utilizes a container with a reaction chamber for receiving the plasma. The reaction chamber is defined by a wall and an agent is supplied to the reaction chamber for converting the fibrinogen content of the plasma into a non-cross-linked fibrin polymer. The method also utilizes a device for centrifuging the reaction chamber with the plasma and the agent to a degree sufficient for separating the non-cross-linked fibrin polymer from the plasma, for depositing the polymer on the outer wall of the reaction chamber, and for expelling the remaining plasma from the reaction chamber. A solvent is supplied to the reaction chamber for dissolving the non-cross-linked fibrin polymer. The solvent is supplied to the reaction chamber in a first amount for dissolving the non-cross-linked fibrin polymer which is less than the total amount of solvent for dissolving the polymer.
Abstract: The invention provides a kit for preparing a fibrin sealant either (A) comprising: (a) a fibrin monomer preparation; (b) a stabilizing preparation containing a clot-preserving effective amount of a fibrinolysis-inhibiting protein; and (c) a non-enzymatic polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot; or (B) comprising: (a′) a fibrin monomer preparation comprising a fibrin monomer and a clot-preserving effective amount of a of a fibrinolysis-inhibiting protein; and (c′) a polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot.
Abstract: A blood processor is provided with a computer and memory, and external to the blood processor there is provided a general purpose computer system programmed with a convenient interface for creating scripts; the general purpose computer system translates the scripts into custom interpretive code adapted for processing by the computer in the blood processor, and the code is written into the memory of the blood processor via the computer in the blood processor.
Abstract: An improved plasma separation device and method involve the use of a retaining means with a centrifugal plasma separation device for retaining unwanted blood components, e.g., lipids or lipoproteins, from passing from a separation chamber in the device to a collection chamber in the device along with the separated plasma.
Abstract: A polyurethane adhesive composition preferably having pressure sensitive characteristics that is non-cytotoxic and methods of making the same which is especially useful for medical applications such as ostomy and wound care.